BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Madhavan M, Ritchie AJ, Aboagye J, Jenkin D, Provstgaad-Morys S, Tarbet I, Woods D, Davies S, Baker M, Platt A, Flaxman A, Smith H, Belij-Rammerstorfer S, Wilkins D, Kelly EJ, Villafana T, Green JA, Poulton I, Lambe T, Hill AVS, Ewer KJ, Douglas AD. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial. EBioMedicine 2022;:104298. [PMID: 36229342 DOI: 10.1016/j.ebiom.2022.104298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Mantovani A, Rescigno M, Forni G, Tognon F, Putoto G, Ictho J, Lochoro P. COVID-19 vaccines and a perspective on Africa. Trends Immunol 2023;44:172-87. [PMID: 36709083 DOI: 10.1016/j.it.2023.01.005] [Reference Citation Analysis]
2 Tang J, Sun J. Lung tissue-resident memory T cells: the gatekeeper to respiratory viral (re)-infection. Curr Opin Immunol 2023;80:102278. [PMID: 36565508 DOI: 10.1016/j.coi.2022.102278] [Reference Citation Analysis]
3 Silva-Sanchez A, Randall TD. Spiking SARS-CoV-2 antiviral immunity in the respiratory tract. Trends Immunol 2023;44:87-9. [PMID: 36593157 DOI: 10.1016/j.it.2022.12.007] [Reference Citation Analysis]
4 Spinardi JR, Srivastava A. Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination-Evidence Synthesis and Implications for New COVID-19 Vaccines. Biomedicines 2023;11. [PMID: 36830907 DOI: 10.3390/biomedicines11020370] [Reference Citation Analysis]
5 Vaca GB, Meyer M, Cadete A, Hsiao CJ, Golding A, Jeon A, Jacquinet E, Azcue E, Guan CM, Sanchez-felix X, Pietzsch CA, Mire CE, Hyde MA, Comeaux ME, Williams JM, Sung JC, Carfi A, Edwards DK, Bukreyev A, Bahl K. Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection.. [DOI: 10.1101/2023.01.11.523616] [Reference Citation Analysis]
6 Marks PW, Gruppuso PA, Adashi EY. Urgent Need for Next-Generation COVID-19 Vaccines. JAMA 2023;329:19-20. [PMID: 36484995 DOI: 10.1001/jama.2022.22759] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Braun MR, Martinez CI, Dora EG, Showalter LJ, Mercedes AR, Tucker SN. Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2. Front Immunol 2023;14:1086035. [PMID: 36911687 DOI: 10.3389/fimmu.2023.1086035] [Reference Citation Analysis]
8 Brazil R. How your first brush with COVID warps your immunity. Nature 2023;613:428-30. [PMID: 36653572 DOI: 10.1038/d41586-023-00086-1] [Reference Citation Analysis]
9 Tedjakusuma SN, Lester CA, Neuhaus ED, Dora EG, Tucker SN, Flitter BA. Adenoviral-Based Vaccine Elicits Robust Systemic and Mucosal Cross-Reactive Responses in African Green Monkeys and Reduces Shedding after SARS-CoV-2 Challenge.. [DOI: 10.1101/2022.12.19.521127] [Reference Citation Analysis]
10 Aksyuk AA, Bansal H, Wilkins D, Stanley AM, Sproule S, Maaske J, Sanikommui S, Hartman WR, Sobieszczyk ME, Falsey AR, Kelly EJ. AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Cell Rep Med 2023;4:100882. [PMID: 36610390 DOI: 10.1016/j.xcrm.2022.100882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Brüssow H. Do we need nasal vaccines against COVID 19 to suppress the transmission of infections? Microb Biotechnol 2023;16:3-14. [PMID: 36464938 DOI: 10.1111/1751-7915.14181] [Reference Citation Analysis]
12 Yu Y, Aboulfotouh K, Williams G, Suman J, Cano C, Warnken ZN, Williams RO, Cui Z. Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive AS01B-adjuvanted vaccine powders.. [DOI: 10.1101/2022.11.01.514748] [Reference Citation Analysis]